ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,028.09
-0.08%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avidity Biosciences Inc (RNA)

  7. Avidity Biosciences Inc (RNA) News

Avidity Biosciences (RNA)

Avidity Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RNA
DateTimeSourceHeadlineSymbolCompany
16/05/202423:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNAAvidity Biosciences Inc
16/05/202423:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RNAAvidity Biosciences Inc
15/05/202414:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RNAAvidity Biosciences Inc
15/05/202414:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNAAvidity Biosciences Inc
15/05/202414:00PR Newswire (US)Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of DirectorsNASDAQ:RNAAvidity Biosciences Inc
09/05/202421:22Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:RNAAvidity Biosciences Inc
09/05/202421:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNAAvidity Biosciences Inc
09/05/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNAAvidity Biosciences Inc
09/05/202421:05PR Newswire (US)Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:RNAAvidity Biosciences Inc
08/05/202421:05PR Newswire (US)Avidity Biosciences to Participate in Upcoming Investor ConferenceNASDAQ:RNAAvidity Biosciences Inc
08/05/202411:00PR Newswire (US)Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC 1001) for Treatment of Myotonic Dystrophy Type 1NASDAQ:RNAAvidity Biosciences Inc
08/05/202402:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNAAvidity Biosciences Inc
22/04/202421:05PR Newswire (US)Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:RNAAvidity Biosciences Inc
27/03/202413:00PR Newswire (US)Avidity Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:RNAAvidity Biosciences Inc
21/03/202420:05PR Newswire (US)Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:RNAAvidity Biosciences Inc
08/03/202421:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RNAAvidity Biosciences Inc
05/03/202421:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNAAvidity Biosciences Inc
04/03/202412:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNAAvidity Biosciences Inc
04/03/202412:00PR Newswire (US)Avidity Biosciences Announces Positive AOC 1001 Long-term Data Showing Reversal of Disease Progression in People Living with Myotonic Dystrophy Type 1 Across Multiple Endpoints; Same Key Endpoints Agreed for Phase 3 HARBOR™ TrialNASDAQ:RNAAvidity Biosciences Inc
01/03/202421:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RNAAvidity Biosciences Inc
29/02/202421:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RNAAvidity Biosciences Inc
29/02/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNAAvidity Biosciences Inc
29/02/202417:00PR Newswire (US)Avidity Biosciences Honors Rare Disease Day®NASDAQ:RNAAvidity Biosciences Inc
29/02/202412:00PR Newswire (US)Avidity Biosciences Announces Oversubscribed $400 Million Private PlacementNASDAQ:RNAAvidity Biosciences Inc
28/02/202422:32Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:RNAAvidity Biosciences Inc
28/02/202421:17Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RNAAvidity Biosciences Inc
28/02/202421:05PR Newswire (US)Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent HighlightsNASDAQ:RNAAvidity Biosciences Inc
27/02/202414:00PR Newswire (US)Avidity Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:RNAAvidity Biosciences Inc
21/02/202421:05PR Newswire (US)Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:RNAAvidity Biosciences Inc
20/02/202414:00PR Newswire (US)Avidity Biosciences Receives FDA Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 SkippingNASDAQ:RNAAvidity Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:RNA

Your Recent History

USOTC
ADCNF
Adicon (PK)
LSE
SHG
Shanta Gold
EU
INGWG
INGWG
AMEX
RZV
Invesco S&P SmallCap 600...
NYSE
AAM-A
Apollo Asset Management
NASDAQ
HWCPL
Hancock Whitney
TSX
MAG
MAG Silver
CRTO
FTMBTC
Fantom Token
BTRX
IOCBTC
I/O Coin
TSX
BITF
Bitfarms
COIN
ACTPBTC
Archetypal Network
LSE
OPG
Opg Power Ventures
LSE
UKOG
Uk Oil & Gas
LSE
STEC
Shieldtech
AMEX
FSEC
Fidelity Investment Grad...
EU
PAX
CAC AllShares
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved